{
    "clinical_study": {
        "@rank": "24982", 
        "arm_group": [
            {
                "arm_group_label": "Local anesthetic continuous infusion", 
                "arm_group_type": "Active Comparator", 
                "description": "Pain management following hernia repair"
            }, 
            {
                "arm_group_label": "Placebo continuous infusion", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo pain management following hernia repair"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary endpoint of this study will determine if subjects receiving a continuous\n      infusion of local anesthetic following laparoscopic ventral hernia repair, with the pain\n      pump installed as described to treat post surgical pain will have a lower incidence of pain\n      than those patients treated with a placebo, saline-filled pain pump.The secondary endpoint\n      of this study will determine if subjects receiving a continuous infusion of local anesthetic\n      following laparoscopic ventral hernia repair, with the pain pump installed as described to\n      treat post surgical pain will have a lower utilization of narcotic analgesic medication than\n      those patients treated with the placebo, saline-filled pain pump."
        }, 
        "brief_title": "Continuous Local Anesthetic Infusion Following Hernia Repair", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Ventral Hernia", 
        "condition_browse": {
            "mesh_term": [
                "Hernia", 
                "Hernia, Ventral"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients will be screened to determine study eligibility using inclusion/exclusion criteria.\n       Following the consent process, subjects will be randomly assigned to a treatment arm\n      (anesthetic or placebo group).  Baseline data will be collected prior surgical implantation\n      of the pain pump delivery system.  Both study and control groups will be able to receive\n      supplemental medication for breakthrough pain as determined by the surgeon.  Post-operative\n      data will be collected up to three weeks following surgery."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        >18 years\n\n          -  ASA I,II,III\n\n          -  Scheduled for Laparoscopic Ventral Hernia Repair\n\n        Exclusion Criteria:\n\n          -  ASA IV or greater\n\n          -  Needing emergency surgery\n\n          -  Known history of drug abuse\n\n          -  GI, liver, kidney or other condition which, per the surgeon's opinion, could\n             interfere with the absorption, distribution, metabolism or excretion of any drug used\n             during the duration of the study\n\n          -  Patients with a prior allergic reaction or dependency to morphine, demerol, dilaudid,\n             fentanyl, marcaine(bupivicaine), lidocaine, or ropivicaine."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01804114", 
            "org_study_id": "EH11-297"
        }, 
        "intervention": {
            "arm_group_label": "Local anesthetic continuous infusion", 
            "description": "Continuous infusion of local anesthetic via pain pump following hernia repair", 
            "intervention_name": "Pain management following hernia repair", 
            "intervention_type": "Procedure", 
            "other_name": "Placement of pain pump to manage post-operative hernia pain"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics, Local", 
                "Anesthetics"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 1, 2013", 
        "location": {
            "contact": {
                "last_name": "Michael Ujiki, MD", 
                "phone": "847-570-1700"
            }, 
            "contact_backup": {
                "email": "jcarbray@northshore.org", 
                "last_name": "JoAnn Carbray", 
                "phone": "847 570 3802"
            }, 
            "facility": {
                "address": {
                    "city": "Evanston", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60201"
                }, 
                "name": "NorthShore University HealthSystem"
            }, 
            "investigator": {
                "last_name": "Michael Ujiki, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Continuous Preperitoneal Infusion of Local Anesthetic Via Pain Pump for Laparoscopic Ventral Hernia Repair", 
        "other_outcome": {
            "description": "Patients will self-report quality of life assessments on questionnaires 3 weeks post-operatively.", 
            "measure": "Post-Operative Quality of Life Score", 
            "safety_issue": "No", 
            "time_frame": "Up to 3 weeks post surgery"
        }, 
        "overall_contact": {
            "last_name": "Michael Ujiki, MD", 
            "phone": "847 570 1700"
        }, 
        "overall_official": {
            "affiliation": "NorthShore University HealthSystem", 
            "last_name": "Michael Ujiki, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients will self-report pain assessments on questionnaires each of the first seven days post-operatively.", 
            "measure": "Post-Operative Pain", 
            "safety_issue": "No", 
            "time_frame": "Up to 7 days post surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01804114"
        }, 
        "responsible_party": {
            "investigator_affiliation": "NorthShore University HealthSystem Research Institute", 
            "investigator_full_name": "Michael Ujiki, M.D.", 
            "investigator_title": "Director of Minimally Invasive Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Patients will be given a diary to record all narcotics taken post-op for pain control.", 
            "measure": "Post-Operative Narcotic Analgesic Use", 
            "safety_issue": "No", 
            "time_frame": "Up to 3 weeks post surgery"
        }, 
        "source": "NorthShore University HealthSystem Research Institute", 
        "sponsors": {
            "collaborator": {
                "agency": "Kimberly-Clark Corporation", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "NorthShore University HealthSystem Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}